MAP — Microba Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- AU$42.23m
- AU$34.58m
- AU$15.67m
- 27
- 52
- 14
- 20
Annual cashflow statement for Microba Life Sciences, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
R2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 1.16 | 2.85 | 3.53 | 7.36 | 6.99 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.18 | -10.4 | -12.4 | -15.6 | -12 |
| Capital Expenditures | -0.672 | -1.87 | -3.04 | -4.38 | -2.9 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.1 | 0.14 | 0.038 | -9.57 | 0.066 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.573 | -1.73 | -3 | -13.9 | -2.83 |
| Financing Cash Flow Items | -0.951 | -1.9 | -0.596 | -1.26 | -0.385 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13.8 | 29.2 | 16.7 | 18.4 | 5.58 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.08 | 17.6 | 1.46 | -11.2 | -9.15 |